In recent years, transmissible strains of P. aeruginosa (PsA) have been described. Data from the Wisconsin newborn screening (NBS) study have shown that infants are at risk of early PsA acquisition from older patients. We have had NBS since 1981 and in May 2003, reorganised our CF service so that children 5 yrs were 'segregated' for outpatient and inpatient care. This study investigated the effect of this change on the acquisition of respiratory pathogens. The results of all sputum cultures (n = 2814 cultures in total) for all children 5 yrs before (1999-2002) and after (2004-2007) 'segregation' were collected. Each year 72−90 children of this age were seen and each child provided an average of 4.6 suction samples for culture per year. The % of children with one or more sputum cultures positive for pathogens of interest in the 4 years before and after 'segregation' are shown. There was a significant decrease (p 0.001, c 2 ) in the acquisition of mucoid but not non-mucoid PsA after 'segregation'. The apparent increase in acquisition of H. influenzae was related to a change in microbiological detection processes during this period. These results suggest that young children diagnosed via NBS may be protected from the acquisition of mucoid PsA from older children by 'segregation' and that the acquisition of non-mucoid PsA in young children is from sources outside the hospital environment, but other factors also need consideration. Prophylactic antibiotic therapy seemed to have a preventive effect in small and retrospective studies, but has not been proven prospectively in a controlled manner. Hypothesis: Prophylactic treatment of PA-negative CF patients will prevent or delay the first acquisition of PA or eradicate PA before the onset of persistent colonization and accompanying pulmonary inflammatory response. Methods: Sixty-eight children (age 0.3−17.0; mean 7.3 y) without PA infection from 4 CF-centres were randomly allocated to 3-monthly courses of 3 weeks oral ciprofloxacin (10 mg/kg bid) and inhaled colistin (1 MIU bid) or both matching placebos during 3 years. Patients, investigators and doctors were blinded for allocation. Patients regularly visited the clinic for evaluation of PA-and clinical status. PA-status was determined by culturing sputa or cough swabs 3-monthly and measuring anti-PA antibodies 6-monthly. The primary endpoint is initial PA infection (2 PA-positive cultures taken 1 week apart or 1 positive culture with pulmonary exacerbation). Secondary endpoints are PA-free interval, anti-PA antibodies, respiratory pathogens, antibiotic use and resistance, number of exacerbations, adverse events, pulmonary function, chest X-ray scores, inflammation parameters and BMI. Results: Trial results (ISRCTN11604593), available May 2009, will be presented and discussed.
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